Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous butylscopolamine infusion versus placebo for renal colic unresponsive to oral NSAIDs
NL-OMON47573Phase 4Completed
- Sponsor
- HagaZiekenhuis
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Renal colic and Lithiasis comparing Butylscopolamine infusion with Placebo infusion (2 arms). Primary endpoint: Pain reduction in Numeric Rating Scale score. Started Jan 2018; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
Renal colicLithiasis
Beyond the preview
Go deeper on NL-OMON47573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47573.